Transcatheter Technologies is a medical device company that has developed a full range of transcatheter valve implantation systems for catheter-based heart valve therapy. Provides Aortic and Mitral Valve Implantation (TAVI and TMVI).
Asset sale to Venus Medtech, a leading heart valve developer in China.
Fuel the continued development of the next-generation technology platform for the treatment of various structural heart diseases in the Chinese market. Enhance valve products presence in the global market and expand number of patients that will benefit from the procedure.
If you would like to learn more information about this transaction contact us below.